Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1996
12/11/1996EP0521080B1 Synergistic compositions
12/11/1996EP0437556B1 Substitution analogues of magainin peptides
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/10/1996US5582821 Administering interleukins
12/10/1996CA2178548A1 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
12/08/1996CA2178355A1 Diazepine containing dual action inhibitors
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038441A1 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038143A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222573A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/04/1996EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases
12/04/1996EP0744944A1 Sexual steroid-containing transdermal therapeutic systems
12/04/1996EP0744943A1 Desogestrel-containing transdermal application agent
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/04/1996CN1137270A Novel imidazole derivative and process for producing the same
12/04/1996CN1137267A N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid derivatives as chelating agents
12/04/1996CN1137037A Quinazoline derivatives
12/04/1996CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/04/1996CN1136936A "Shenyankangle"-medicine for treating nephritis
12/04/1996CN1136926A Chinese medicine for treating acute and chronic nephritis
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580864 Method of controlling male fertility
12/03/1996US5580542 Method of testing for nephritis
11/1996
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996WO1996037209A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
11/28/1996WO1996037204A1 Inhibitors of farnesyl-protein transferase
11/28/1996WO1996037202A1 Dosage form comprising oxybutynin
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996CA2510391A1 Dosage form comprising oxybutynin
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221701A1 Inhibitors of farnesyl-protein transferase
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/28/1996CA2218018A1 Method of administration of igf-i
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0743954A1 Methods for variation of chromatin condensation
11/27/1996CN1136779A Long-acting injection suspensions and process for their preparation
11/27/1996CN1136434A Application of di-caffee acyl-oxy-quininic acid in pharmacy
11/26/1996US5578724 Process for preparation of benzo[f]quinolinones
11/26/1996US5578611 Antitumor agents and prostate tumor detection by binding human alpha-adrenergic receptor and histamine h1 receptors
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996027375A3 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996CN1136039A |3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy¨-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576290 Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction
11/19/1996US5576287 Method for treating acute renal disease and failure
11/14/1996WO1996035671A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/14/1996CA2220538A1 .beta.-adrenergic agonists
11/14/1996CA2220399A1 .beta.-adrenergic agonists
11/13/1996EP0741708A1 Cyanoguanidines as k-channel blockers
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741578A1 Human growth hormone
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996CN1135177A Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
11/05/1996US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
11/05/1996US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
11/05/1996US5571813 Treatment of hypertension, congestive heart failure, renal failure
10/1996
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996033705A1 Methods and formulations for modulating the human sexual response
10/30/1996EP0739633A2 Use of antithrombin III to increase placental blood flow
10/30/1996CN1134699A Succinamic acid compound, process for producing the same, and use thereof
10/30/1996CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM
10/30/1996CN1134423A Adhesion receptor antagonists
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134417A 2,8-disubstituted quinazolinones
10/29/1996US5569768 Angiotensin II antagonists
10/24/1996WO1996033169A1 1-[φ-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME
10/24/1996WO1996032954A1 Nitrosylated neuropeptides
10/24/1996WO1996032939A1 USE OF α1L AGONISTS IN THE TREATMENT OF INCONTINENCE
10/24/1996WO1996032938A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996WO1996017953A3 Genetic basis of factor xiii activity
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 562